Symposium T1: Integrated Development of New Therapeutics for Global Health

Monday 22 May 2017
15:00-18:00
Stockholmsmässan : K16

Chair: Dan Hartman, Bill & Melinda Gates Foundation, USA

Programme

15:00 – 15:10 General introduction: Integrated Development of New Therapeutics for Global Health
Dan Hartman, Bill & Melinda Gates Foundation, USA

15:10 – 15:45 Accelerators: Creating collaborative networks to advance drug discovery for tuberculosis
Peter Warner, Bill & Melinda Gates Foundation, USA

15:45 – 16:20 Formulators:  Bringing new technologies forward in drug formulation to address Global Health needs
Susan Hershenson, Bill & Melinda Gates Foundation, USA

16:20 – 16:40 BREAK

16:40 – 17:15 Quantitators:  Using model based drug development to effectively develop anti- malarial agents
Steve Kern, Bill & Melinda Gates Foundation, USA

17:15 – 17:50 Regulators:  Optimizing and aligning regulatory systems to help bring quality medicines to global health needs
Murray Lumpkin, Bill & Melinda Gates Foundation, USA 

17:50 – 18:00 Concluding remarks: Integrated Development of New Therapeutics for Global Health
Dan Hartman, Bill & Melinda Gates Foundation, USA